Cypress Capital Group’s GE HealthCare GEHC Stock Holding History

Cypress Capital Group’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,850	Closed	-$267K	–	277
2024 Q3	$267K	Buy	+2,850	New	+$239K	0.03%	269

Other funds holding GEHC

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Cypress Capital Group's GEHC Position: Q4 2024 in Review

Cypress Capital Group sold out of GE HealthCare (GEHC) in Q4 2024, closing a stake of 2,850 shares — an estimated $267K sold.

Cypress Capital Group first reported a position in GEHC in Q3 2024 and held it in 1 quarter. The position peaked at $267K in Q3 2024. 1,327 funds tracked by Wall St. Rank hold GEHC as of Q4 2024.

Cypress Capital Group reported no remaining GE HealthCare position as of Q4 2024 after selling out during the quarter.
Cypress Capital Group sold 2,850 GE HealthCare shares in Q4 2024, an estimated $267K.
Cypress Capital Group first reported a position in GE HealthCare in Q3 2024 and held it in 1 quarter.
Cypress Capital Group's GE HealthCare position peaked at $267K in Q3 2024.
1,327 funds tracked by Wall St. Rank held GE HealthCare as of Q4 2024.

Based on Cypress Capital Group's 13F filing for Q4 2024, filed 6 Feb 2025.